Lysophosphatidic acid-induced platelet shape change revealed through LPA(1-5) receptor-selective probes and albumin.
D000818:Animals; D001792:Blood Platelets / Q000187:drug effects* / Q000378:metabolism / Q000648:ultrastructure; D016466:CHO Cells; D048430:Cell Shape / Q000187:drug effects; D006224:Cricetinae; D003412:Cricetulus; D000242:Cyclic AMP / Q000097:blood; D005260:Female; D006801:Humans; D008246:Lysophospholipids / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D008297:Male; D008956:Models, Chemical; D010712:Phosphatidic Acids / Q000494:pharmacology; D015539:Platelet Activation / Q000187:drug effects / Q000502:physiology; D012333:RNA, Messenger / Q000096:biosynthesis / Q000097:blood / Q000235:genetics; D051381:Rats; D049368:Receptors, Lysophosphatidic Acid / Q000819:agonists / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000097:blood*; D012710:Serum Albumin, Bovine / Q000737:chemistry / Q000494:pharmacology*; D013329:Structure-Activity Relationship
D008246:Lysophospholipids; D010712:Phosphatidic Acids; D012333:RNA, Messenger; D049368:Receptors, Lysophosphatidic Acid; D012710:Serum Albumin, Bovine; D000242:Cyclic AMP